Showing 321 - 340 results of 3,105 for search '"amyotrophic lateral sclerosis"', query time: 0.14s Refine Results
  1. 321
  2. 322
  3. 323
  4. 324
  5. 325

    T cell responses at diagnosis of amyotrophic lateral sclerosis predict disease progression by Solmaz Yazdani, Christina Seitz, Can Cui, Anikó Lovik, Lu Pan, Fredrik Piehl, Yudi Pawitan, Ulf Kläppe, Rayomand Press, Kristin Samuelsson, Li Yin, Trung Nghia Vu, Anne-Laure Joly, Lisa S. Westerberg, Björn Evertsson, Caroline Ingre, John Andersson, Fang Fang

    Published 2022-11-01
    “…Amyotrophic lateral sclerosis (ALS) is a primary neurodegenerative disease, which is characterized by increased immune cell infiltration of the central nervous system. …”
    Get full text
    Article
  6. 326
  7. 327
  8. 328

    The landscape of cognitive impairment in superoxide dismutase 1-amyotrophic lateral sclerosis by Ilaria Martinelli, Elisabetta Zucchi, Cecilia Simonini, Giulia Gianferrari, Giovanna Zamboni, Marcello Pinti, Jessica Mandrioli

    Published 2023-01-01
    Subjects: “…amyotrophic lateral sclerosis; cognitive impairment; genotype-phenotype correlation; superoxide dismutase 1…”
    Get full text
    Article
  9. 329
  10. 330
  11. 331

    Target Metabolites to Slow Down Progression of Amyotrophic Lateral Sclerosis in Mice by Destiny Ogbu, Yongguo Zhang, Katerina Claud, Yinglin Xia, Jun Sun

    Published 2022-12-01
    “…Microbial metabolites affect the neuron system and muscle cell functions. Amyotrophic lateral sclerosis (ALS) is a multifactorial neuromuscular disease. …”
    Get full text
    Article
  12. 332
  13. 333
  14. 334

    Multiple Roles of Transforming Growth Factor Beta in Amyotrophic Lateral Sclerosis by Mariarita Galbiati, Valeria Crippa, Paola Rusmini, Riccardo Cristofani, Elio Messi, Margherita Piccolella, Barbara Tedesco, Veronica Ferrari, Elena Casarotto, Marta Chierichetti, Angelo Poletti

    Published 2020-06-01
    “…Transforming growth factor beta (TGFB) is a pleiotropic cytokine known to be dysregulated in many neurodegenerative disorders and particularly in amyotrophic lateral sclerosis (ALS). This motor neuronal disease is non-cell autonomous, as it affects not only motor neurons but also the surrounding glial cells, and the target skeletal muscle fibers. …”
    Get full text
    Article
  15. 335
  16. 336

    Juvenile amyotrophic lateral sclerosis type 4: case report and review by G. E. Rudenskaya, S. S. Nikitin, O. L. Shatokhina, O. A. Shchagina

    Published 2022-09-01
    “…Juvenile amyotrophic lateral sclerosis (ALS) presents a group of few rare monogenic disorders with onset from early childhood up to 25 years and much more benign course than “classic” ALS. …”
    Get full text
    Article
  17. 337
  18. 338

    Characterization of FUS Mutations in Amyotrophic Lateral Sclerosis Using RNA-Seq by van Blitterswijk, Marka, Wang, Eric T., Friedman, Brad Aaron, Keagle, Pamela J., Lowe, Patrick, Leclerc, Ashley Lyn, van den Berg, Leonard H., Housman, David E., Veldink, Jan H., Landers, John E.

    Published 2013
    “…Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease resulting in severe muscle weakness and eventual death by respiratory failure. …”
    Get full text
    Get full text
    Article
  19. 339
  20. 340